Alpha-Momorcharin Inhibits Proinflammatory Cytokine Expression by M1 Macrophages but Not Anti-Inflammatory Cytokine Expression by M2 Macrophages

References

• Puri M, Kaur I, Kanwar RK, et al. Ribosome inactivating proteins (RIPs) from Momordica charantia for antiviral therapy. Curr Mol Med. 2009;9(9):1080–1094. doi:10.2174/156652409789839071
   PubMed Web of Science ®Google Scholar
• Ng TB, Wong JH, Wang H. Recent progress in research on ribosome inactivating proteins. Curr Protein Pept Sci. 2010;11(1):37–53. doi:10.2174/138920310790274662
   PubMed Web of Science ®Google Scholar
• Leung SO, Yeung HW, Leung KN. The immunosuppressive activities of two abortifacient proteins isolated from the seeds of bitter melon (Momordica charantia). Immunopharmacology. 1987;13(3):159–171. doi:10.1016/0162-3109(87)90054-3
   PubMed Web of Science ®Google Scholar
• Deng N, Li M, Shen D, et al. LRP1 receptor-mediated immunosuppression of α-MMC on monocytes. Int Immunopharmacol. 2019;70:80–87. doi:10.1016/j.intimp.2019.01.036
   PubMed Web of Science ®Google Scholar
• Deng N, Sun Y, Liu M, et al. Alpha-momorcharin regulates cytokine expression and induces apoptosis in monocytes. Immunopharmacol Immunotoxicol. 2019;41(2):258–266. doi:10.1080/08923973.2019.1610430
   PubMed Web of Science ®Google Scholar
• Wang L, Shen F, Zhang M, et al. Cytotoxicity mechanism of α-MMC in normal liver cells through LRP1 mediated endocytosis and JNK activation. Toxicology. 2016;357–358:33–43. doi:10.1016/j.tox.2016.05.025
   PubMed Web of Science ®Google Scholar
• Chen YJ, Zhu JQ, Fu XQ, et al. Ribosome-inactivating protein α-momorcharin derived from edible plant momordica charantia induces inflammatory responses by activating the NF-kappaB and JNK pathways. Toxins. 2019;11(12):694. doi:10.3390/toxins11120694
   PubMed Web of Science ®Google Scholar
• Veremeyko T, Yung AWY, Anthony DC, et al. Early growth response gene-2 is essential for M1 and M2 macrophage activation and plasticity by modulation of the transcription factor CEBPβ. Front Immunol. 2018;9:2515. doi:10.3389/fimmu.2018.02515
   PubMed Web of Science ®Google Scholar
• Khallou-Laschet J, Varthaman A, Fornasa G, et al. Macrophage plasticity in experimental atherosclerosis. PLoS One. 2010;5(1):e8852. doi:10.1371/journal.pone.0008852
   PubMed Web of Science ®Google Scholar
• Cherry JD, Olschowka JA, O’Banion MK. Neuroinflammation and M2 microglia: the good, the bad, and the inflamed. J Neuroinflammation. 2014;11:98. doi:10.1186/1742-2094-11-98
   PubMed Web of Science ®Google Scholar
• Lu YC, Yeh WC, Ohashi PS. LPS/TLR4 signal transduction pathway. Cytokine. 2008;42(2):145–151. doi:10.1016/j.cyto.2008.01.006
   PubMed Web of Science ®Google Scholar
• Peri F, Piazza M, Calabrese V, et al. Exploring the LPS/TLR4 signal pathway with small molecules. Biochem Soc Trans. 2010;38(5):1390–1395. doi:10.1042/BST0381390
   PubMed Web of Science ®Google Scholar
• He Y, Gao Y, Zhang Q, et al. IL-4 switches Microglia/macrophage M1/M2 polarization and alleviates neurological damage by modulating the JAK1/STAT6 pathway following ICH. Neuroscience. 2020;437:161–171. doi:10.1016/j.neuroscience.2020.03.008
   PubMed Web of Science ®Google Scholar
• Li M, Chen Y, Liu Z, et al. Anti-tumor activity and immunological modification of ribosome-inactivating protein (RIP) from Momordica charantia by covalent attachment of polyethylene glycol. Acta Biochim Biophys Sin. 2009;41(9):792–799. doi:10.1093/abbs/gmp068
   Google Scholar
• Meng Y, Lin S, Liu S, et al. A novel method for simultaneous production of two ribosome-inactivating proteins, α-MMC and MAP30, from Momordica charantia L. PLoS One. 2014;9(7):e101998. doi:10.1371/journal.pone.0101998
   PubMed Web of Science ®Google Scholar
• Percie du Sert N, Hurst V, Ahluwalia A, et al. The ARRIVE guidelines 2.0: updated guidelines for reporting animal research. PLoS Biol. 2020;18(7):e3000410. doi:10.1371/journal.pbio.3000410
   PubMed Web of Science ®Google Scholar
• Tanino Y, Makita H, Miyamoto K, et al. Role of macrophage migration inhibitory factor in bleomycin-induced lung injury and fibrosis in mice. Am J Physiol Lung Cell Mol Physiol. 2002;283(1):L156–62. doi:10.1152/ajplung.00155.2001
   PubMed Web of Science ®Google Scholar
• Shapouri-Moghaddam A, Mohammadian S, Vazini H, et al. Macrophage plasticity, polarization, and function in health and disease. J Cell Physiol. 2018;233(9):6425–6440. doi:10.1002/jcp.26429
   PubMed Web of Science ®Google Scholar
• Locati M, Curtale G, Mantovani A. Diversity, mechanisms, and significance of macrophage plasticity. Annu Rev Pathol. 2020;15:123–147. doi:10.1146/annurev-pathmechdis-012418-012718
   PubMed Web of Science ®Google Scholar
• Behrens EM, Koretzky GA. Review: cytokine storm syndrome: looking toward the precision medicine era. Arthritis Rheumatol. 2017;69(6):1135–1143. doi:10.1002/art.40071
   PubMed Web of Science ®Google Scholar
• Fajgenbaum DC, June CH. Cytokine Storm. N Engl J Med. 2020;383(23):2255–2273. doi:10.1056/NEJMra2026131
   PubMed Web of Science ®Google Scholar
• Song P, Li W, Xie J, et al. Cytokine storm induced by SARS-CoV-2. Clin Chim Acta. 2020;509:280–287. doi:10.1016/j.cca.2020.06.017
   PubMed Web of Science ®Google Scholar
• Hu B, Huang S, Yin L. The cytokine storm and COVID-19. J Med Virol. 2021;93(1):250–256. doi:10.1002/jmv.26232
   PubMed Web of Science ®Google Scholar
• Sen ES, Clarke SL, Ramanan AV. Macrophage Activation Syndrome. Indian J Pediatr. 2016;83(3):248–253. doi:10.1007/s12098-015-1877-1
   PubMed Web of Science ®Google Scholar
• Crayne CB, Albeituni S, Nichols KE, et al. The immunology of macrophage activation syndrome. Front Immunol. 2019;10:119. doi:10.3389/fimmu.2019.00119
   PubMed Web of Science ®Google Scholar
• McGonagle D, Sharif K, O’Regan A, et al. The role of cytokines including interleukin-6 in COVID-19 induced pneumonia and macrophage activation syndrome-like disease. Autoimmun Rev. 2020;19(6):102537. doi:10.1016/j.autrev.2020.102537
   PubMed Web of Science ®Google Scholar
• Finkin-Groner E, Moradov D, Shifrin H, et al. Indoline-3-propionate and 3-aminopropyl carbamates reduce lung injury and pro-inflammatory cytokines induced in mice by LPS. Br J Pharmacol. 2015;172(4):1101–1113. doi:10.1111/bph.12982
   PubMed Web of Science ®Google Scholar
• Hu X, Tian Y, Qu S, et al. Protective effect of TM6 on LPS-induced acute lung injury in mice. Sci Rep. 2017;7(1):572. doi:10.1038/s41598-017-00551-8
   PubMed Web of Science ®Google Scholar
• Kanehisa M, Goto S, Sato Y, et al. KEGG for integration and interpretation of large-scale molecular data sets. Nucleic Acids Res. 2012;40(Database issue):D109–14. doi:10.1093/nar/gkr988
   PubMed Web of Science ®Google Scholar
• McAlister GC, Huttlin EL, Haas W, et al. Increasing the multiplexing capacity of TMTs using reporter ion isotopologues with isobaric masses. Anal Chem. 2012;84(17):7469–7478. doi:10.1021/ac301572t
   PubMed Web of Science ®Google Scholar
• Ravelli A, Davì S, Minoia F, et al. Macrophage activation syndrome. Hematol Oncol Clin North Am. 2015;29(5):927–941. doi:10.1016/j.hoc.2015.06.010
   PubMed Web of Science ®Google Scholar
• Akdis CA, Blesken T, Akdis M, et al. Glucocorticoids inhibit human antigen-specific and enhance total IgE and IgG4 production due to differential effects on T and B cells in vitro. Eur J Immunol. 1997;27(9):2351–2357. doi:10.1002/eji.1830270933
   PubMed Web of Science ®Google Scholar
• Rupprecht R, Wodarz N, Kornhuber J, et al. In vivo and in vitro effects of glucocorticoids on lymphocyte proliferation in man: relationship to glucocorticoid receptors. Neuropsychobiology. 1991;24(2):61–66. doi:10.1159/000119462
   Web of Science ®Google Scholar
• Vandewalle J, Luypaert A, De Bosscher K, et al. Therapeutic mechanisms of glucocorticoids. Trends Endocrinol Metab. 2018;29(1):42–54. doi:10.1016/j.tem.2017.10.010
   PubMed Web of Science ®Google Scholar
• Hartmann K, Koenen M, Schauer S, et al. Molecular actions of glucocorticoids in cartilage and bone during health, disease, and steroid therapy. Physiol Rev. 2016;96(2):409–447. doi:10.1152/physrev.00011.2015
   PubMed Web of Science ®Google Scholar
• Escoter-Torres L, Caratti G, Mechtidou A, et al. Fighting the fire: mechanisms of inflammatory gene regulation by the glucocorticoid receptor. Front Immunol. 2019;10:1859. doi:10.3389/fimmu.2019.01859
   PubMed Web of Science ®Google Scholar